Source link : https://www.newshealth.biz/health-news/glp-1-discontinuation-less-common-with-endocrinologists/
Patients taking glucagon-like peptide 1 (GLP-1) receptor agonists for obesity appear to be discontinuing the medications before they can have any meaningful impact on weight loss, according to two new studies. In a large Blue Cross Blue Shield claims database, only about 42% of those prescribed the medications stayed on them beyond the 12 weeks […]
Author : News Health
Publish date : 2024-06-10 11:05:47
Copyright for syndicated content belongs to the linked Source.
Categories